Reference 2021-30

REF: 2021-30      

    

Subject: Bevacizumab     

 

 

Request:

Could you please provide answers to the following two questions about the usage of the drug Bevacizumab:

  1. How many patients have been treated by your trust (for any medical condition) in the past 6 months with Bevacizumab?
  2. Please provide the number of patients treated in the past 6 months with Bevacizumab for the following conditions:
  • Colorectal cancer
  • Breast cancer
  • Renal cell carcinoma
  • Non-small cell lung cancer
  • Ovarian cancer (epithelial, fallopian tube or primary peritoneal)
  • Carcinoma of the cervix

 

Response:

Could you please provide answers to the following two questions about the usage of the drug Bevacizumab:
1. How many patients have been treated by your trust (for any medical condition) in the past 6 months with Bevacizumab? 0
2. Please provide the number of patients treated in the past 6 months with Bevacizumab for the following conditions:

 

·         Colorectal cancer

·         Breast cancer

·         Renal cell carcinoma

·         Non-small cell lung cancer

·         Ovarian cancer (epithelial, fallopian tube or primary peritoneal)

·         Carcinoma of the cervix

None